2025-08-08 - Analysis Report
Okay, here's a report summarizing the analysis of UnitedHealth Group Inc (UNH), presented in English with simplified numbers and analysis:

**Report on UnitedHealth Group Inc (UNH)**

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and services.

**1. Performance vs. S&P 500 (VOO):**

*   **UNH Cumulative Return:** -19.34%
*   **VOO Cumulative Return:** 82.59%
*   **Relative Divergence (vs. VOO):**
    *   Current Divergence: -115.7
    *   Max Divergence: 16.8
    *   Min Divergence: -116.0
    *   Relative Divergence Position: 0.2

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO). The current divergence is near the lowest point of the historical range. The Relative Divergence Position of 0.2 indicates UNH's underperformance is near its historical worst relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | -1.0%    | 1.0%    | -4.0%   | -1.2   | 200.0  |
| 2016-2018  | 0.0%    | 63.4%   | 4.0%    | 0.1    | 226.0  |
| 2017-2019  | 21.0%   | 63.4%   | -2.0%   | 0.0    | 266.7  |
| 2018-2020  | 7.0%    | 63.4%   | -20.0%  | 0.1    | 318.1  |
| 2019-2021  | 43.0%   | 60.6%   | -6.0%   | 0.2    | 455.5  |
| 2020-2022  | 32.0%   | 66.6%   | 26.0%   | 0.5    | 480.9  |
| 2021-2023  | 33.0%   | 67.5%   | 13.0%   | 0.5    | 477.6  |
| 2022-2024  | -19.0%  | 68.7%   | -46.0%  | 0.3    | 458.9  |
| 2023-2025  | -60.0%  | 75.5%   | -108.0% | 0.1    | 221.9  |

**Analysis:**
*   **Alpha:** Alpha is often negative, especially in more recent periods, indicating underperformance relative to the benchmark.
*   **Beta:** Beta values are generally low, suggesting UNH's price is not highly correlated with the overall market.
*   **CAGR:** The recent CAGR is significantly negative.
*   **MDD:** Maximum Drawdown has been relatively high, indicating substantial peak-to-trough declines in some periods.

**2. Recent Price Action:**

*   **Current Price:** 244.67
*   **Previous Close:** 245.78
*   **Change:** -0.45
*   **5-Day Moving Average:** 244.04
*   **20-Day Moving Average:** 272.90
*   **60-Day Moving Average:** 293.88

**Analysis:** The stock is trading below its 20-day and 60-day moving averages, suggesting a recent downtrend. The slight price decrease indicates a small downward pressure on the stock.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.3318 (Low Risk)
*   **RSI:** 31.42 (Approaching Oversold)
*   **PPO:** -0.992
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (3 shares - Caution - MRI:0.33) Monthly invest 0.8% of total investment ($1,000.00)
*   **Recent (20-day) Relative Divergence Change:** 0.1 (Slight Positive Shift)
*   **Expected Return (%):** -2216.2%

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI suggests the stock might be approaching oversold territory.
*   The Hybrid Signal recommends a cautious approach, suggesting buying a limited number of shares.
*   The recent positive change in relative divergence indicates a short-term upward movement.
*   **The significantly negative expected return should be treated with caution.** This number seems exceptionally low. It warrants investigation as it could be an error or reflect a very pessimistic model.

**4. Recent News & Events:**

*   **August 7, 2025:** Major business developments, regulatory changes, or market events.
*   **August 4, 2025:** Analyst discussions regarding recent performance and industry trends.
*   **August 5, 2025:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **August 8, 2025:** Market experts highlighting both risks and opportunities.

**Analysis:** The news suggests recent events are influencing the stock, with volatility and both risks and opportunities being highlighted. Investors should monitor these developments closely.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2025-05-07 | 6.90  | 109.58 B$     |
| 2024-11-04 | 6.56  | 100.82 B$     |
| 2024-08-09 | 4.58  | 98.86 B$      |
| 2024-05-09 | -1.53 | 99.80 B$     |
| 2025-05-07 | -1.53 | 99.80 B$     |

**Analysis:** Revenue is generally increasing. However, EPS shows volatility, with a significant negative EPS in one of the quarters.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue      | Profit Margin |
|------------|--------------|---------------|
| 2025-03-31 | $109.58B    | 21.70%        |
| 2024-12-31 | $100.81B    | 21.14%        |
| 2024-09-30 | $100.82B    | 22.84%        |
| 2024-06-30 | $98.86B     | 22.31%        |
| 2024-03-31 | $99.80B     | 23.05%        |

**Capital and Profitability:**

| Quarter    | Equity       | ROE     |
|------------|--------------|---------|
| 2025-03-31 | $95.04B    | 6.62%   |
| 2024-12-31 | $92.66B    | 5.98%   |
| 2024-09-30 | $94.53B    | 6.41%   |
| 2024-06-30 | $89.36B     | 4.72%   |
| 2024-03-31 | $86.69B    | -1.63%   |

**Analysis:**

*   Revenue is generally growing, suggesting solid top-line performance.
*   Profit margins are relatively stable.
*   Equity is increasing over time.
*   ROE shows variability, with a negative value in one quarter.

**7. Overall Summary:**

UNH has significantly underperformed the S&P 500 recently. Recent news suggests volatility and the potential for both risks and opportunities. The stock is in a short-term downtrend, with technical indicators showing a potential oversold condition. Revenue and profit margins are generally positive, but EPS and ROE have shown variability. The expected return is exceptionally negative, warranting further investigation.

**Recommendation:**

Given the underperformance, recent volatility, and negative expected return (which needs verification), a **cautious approach** is warranted. Monitor the stock closely for any further developments and consider the risks before making any investment decisions. Further investigation into the extremely negative expected return is crucial.
